Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
(NASDAQ: DNLI) Delayed: 20.13 --0 (-0%)
Previous Close $20.13    52 Week High
Open $20.13    52 Week Low
Day High $20.13    P/E N/A 
Day Low $20.13    EPS
Volume 35